Prevalence of cardiac abnormalities and heart failure in unselected out-patients with type 2 diabetes mellitus and associated clinical factors: Real-world evidence from an Indian registry

被引:1
|
作者
Rajput, Rajesh [1 ]
Mohan, J. C. [2 ]
Sawhney, J. P. S. [3 ]
Dalal, Jamshed [4 ]
Mullasari, Ajit [5 ]
Vasnawala, Hardik [6 ]
Kumar, Amit [6 ]
Hs, Bharath [6 ]
Sarda, Shital [6 ]
机构
[1] PGIMS, Rohtak, India
[2] Jaipur Golden Hosp, Inst Heart & Vasc Dis, Sect 3, New Delhi, India
[3] Sir Ganga Ram Hosp, Delhi, India
[4] Kokilaben Dhirubhai Ambani Hosp, Mumbai, India
[5] MMM Hosp, Chennai, India
[6] AstraZeneca Pharm India Ltd, Med Affairs, Kochi, India
关键词
2-D echocardiography; Heart failure; Left ventricular dysfunction; Type 2 diabetes mellitus; LEFT-VENTRICULAR DYSFUNCTION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; CHAMBER QUANTIFICATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; GUIDELINES; UPDATE;
D O I
10.1016/j.ihj.2023.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Type 2 diabetes mellitus (T2DM) is known to be associated with development of left ventricular (LV) dysfunction and heart failure (HF). The study aimed to determine the prevalence of LV dysfunction and HF in unselected out-patients with T2DM with no previous cardiac history and to correlate LV dysfunction and HF with demographic and comorbid characteristics.Methods: This cross-sectional study conducted at 27 centers in India captured demographic and clinical data through electronic case record forms. B-type natriuretic peptide of >105 pg/mL was used to diagnose HF and two-dimensional echocardiography was used to assess LV dysfunction.Results: Of the 615 patients, 54.3 % (n = 334) were males; mean age was 57.4 +/- 10.48 years. More than one-third of the patients had T2DM duration of >10 years (n = 238; 38.7 %), with hypertension as the most prevalent comorbidity (n = 372, 78.6 %). Approximately 61.3 % of the patients had LV hypertrophy. The mean LV mass was 135.0 +/- 56.16 g (95 % CI 130.28, 139.70). The prevalence of any type of LV dysfunction, including systolic or diastolic dysfunction and HF was 55 % (95 % CI 51.0, 59.0) and 10 % (95 % CI 7.0, 12.0), respectively. A negligible but statistically significant correlation was observed between LV dysfunction and T2DM duration (p = 0.011), alongside HF and age (p < 0.0001).Conclusion: Real-world data from this registry from India demonstrates a substantial burden of LV dysfunction and HF in individuals with T2DM in India. It is imperative to formulate strategies for early identification of LV dysfunction in individuals with T2DM for prevention and consequent management of HF.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 50 条
  • [21] Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT) (vol 21, pg 415, 2019)
    Viswanathan, Vijay
    Singh, K. P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (09) : 531 - 531
  • [22] Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry
    Mclean, Robert R.
    Sima, Adam P.
    Beaty, Silky
    Low, Robert
    Spitzer, Rebecca L.
    Stark, Jeffrey L.
    Lesser, Elizabeth
    Lee, Edward
    Armstrong, April
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2739 - 2751
  • [23] Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry
    Robert R. McLean
    Adam P. Sima
    Silky Beaty
    Robert Low
    Rebecca L. Spitzer
    Jeffrey L. Stark
    Elizabeth Lesser
    Edward Lee
    April Armstrong
    Dermatology and Therapy, 2023, 13 : 2739 - 2751
  • [24] Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review
    Davies, M. J.
    Gagliardino, J. J.
    Gray, L. J.
    Khunti, K.
    Mohan, V.
    Hughes, R.
    DIABETIC MEDICINE, 2013, 30 (05) : 512 - 524
  • [25] Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set
    Pantalone, Kevin M.
    Misra-Hebert, Anita D.
    Hobbs, Todd M.
    Ji, Xinge
    Kong, Sheldon X.
    Milinovich, Alex
    Weng, Wayne
    Bauman, Janine
    Ganguly, Rahul
    Burguera, Bartolome
    Kattan, Michael W.
    Zimmerman, Robert S.
    DIABETES CARE, 2018, 41 (07) : E113 - E114
  • [26] Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry
    Echouffo-Tcheugui, Justin B.
    Xu, Haolin
    DeVore, Adam D.
    Schulte, Phillip J.
    Butler, Javed
    Yancy, Clyde W.
    Bhatt, Deepak L.
    Hernandez, Adrian F.
    Heidenreich, Paul A.
    Fonarow, Gregg C.
    AMERICAN HEART JOURNAL, 2016, 182 : 9 - 20
  • [27] FIBRATE USE IS ASSOCIATED WITH A LOWER INCIDENCE OF HEART FAILURE: A REAL-WORLD STUDY AMONG PEOPLE WITH TYPE 2 DIABETES
    Morieri, M. L.
    Rigato, M.
    Fagarazzi, C.
    Avogaro, A.
    Fadini, G. P.
    ATHEROSCLEROSIS, 2023, 379 : S191 - S191
  • [28] Real-World Study of Delayed Initiation of Insulin and Associated Factors Among Elderly Patients With Type 2 Diabetes Mellitus (T2DM)
    Bhattacharya, Rituparna
    Zhou, Steve
    Wei, Wenhui
    Ajmera, Mayank
    Ling, John
    Sambamoorthi, Usha
    DIABETES, 2013, 62 : A323 - A323
  • [29] Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands
    Pouwer, F.
    Geelhoed-Duijvestijn, P. H. L. M.
    Tack, C. J.
    Bazelmans, E.
    Beekman, A. -J.
    Heine, R. J.
    Snoek, F. J.
    DIABETIC MEDICINE, 2010, 27 (02) : 217 - 224
  • [30] Probiotic Supplementation (Vibact DS) in Patients with Type 2 Diabetes Mellitus: Real-world Experience from India
    Gupta, Sunil
    Kamat, Tejas
    Chawla, Rajeev
    Abhyankar, Mahesh V.
    Revankar, Santosh
    Walia, Silki
    JOURNAL OF DIABETOLOGY, 2022, 13 (01) : 101 - 105